Povacoat affecting solid-state polymorphic changes of indomethacin after co-evaporation from different types of solvents via conventional and microwave drying techniques

Avdeef, 2003

Kerns, 2001, High throughput physicochemical profiling for drug discovery, J Pharm Sci, 90, 1838, 10.1002/jps.1134

Kumar, 2013, Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review, Crit Rev Ther Drug Carrier Syst, 30, 217, 10.1615/CritRevTherDrugCarrierSyst.2013005964

Kawabata, 2011, Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications, Int J Pharm, 420, 1, 10.1016/j.ijpharm.2011.08.032

Kumar, 2013, Pharmaceutical solid dispersion technology: a strategy to improve dissolution of poorly water-soluble drugs, Recent Pat Drug Deliv Formul, 7, 111, 10.2174/18722113113079990009

Alam, 2012, Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates, Expert Opin Drug Deliv, 9, 1419, 10.1517/17425247.2012.732064

Bhatnagar, 2014, Solid dispersion in pharmaceutical drug development: from basics to clinical applications, Curr Drug Deliv, 11, 155, 10.2174/15672018113109990044

Sapkal1, 2013, An overview on the mechanisms of solubility and dissolution rate enhancement in solid dispersion, Int J PharmTech Res, 5, 31

Williams, 2013, Strategies to address low drug solubility in discovery and development, Pharmacol Rev, 65, 315, 10.1124/pr.112.005660

Wegiel, 2014, Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions, J Pharm Pharmacol, 66, 244, 10.1111/jphp.12079

Van Eerdenbrugh, 2010, Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation, Mol Pharm, 7, 1328, 10.1021/mp1001153

Ali, 2012, Challenges and opportunities in oral formulation development, Am Pharm Rev, 15

Newman, 2012, Assessing the performance of amorphous solid dispersions, J Pharm Sci, 101, 1355, 10.1002/jps.23031

Reintjes, 2011

Hoshi, 2003, Development of PVA copolymer capsules, Pharm Tech Japan, 19, 1

Hoshi, 2004, Development of PVA copolymer capsules, Pharm Tech Eur, 16, 37

Hoshi, 2008, Creating PVA copolymer capsules, Pharm Tech Eur, 20, 17

Daido Chemical Corporation, 2010

Fujii, 2005, Development of a new coating agent, PVA copolymer (I), Pharm Tech Japan, 21, 257

Fujii, 2008, PVA copolymer: the new coating agent, Pharm Tech Eur, 20, 32

Kojo, 2009, Development of a new coating agent, PVA copolymer (II), Pharm Tech Japan, 25, 369

Lin, 2011, DSC-FTIR microspectroscopy used to investigate the thermal-induced intramolecular cyclic anhydride formation between Eudragit E and PVA copolymer, Polym J, 43, 577, 10.1038/pj.2011.15

Yuminoki, 2014, Preparation and evaluation of high dispersion stable nanocrystal formulation of poorly water-soluble compounds by using Povacoat, J Pharm Sci, 103, 3772, 10.1002/jps.24147

Ochi, 2014, Development of nanocrystal formulation of meloxicam with improved dissolution and pharmacokinetic behaviors, Int J Pharm, 474, 151, 10.1016/j.ijpharm.2014.08.022

Xu, 2014, Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier, Drug Dev Ind Pharm, 40, 126, 10.3109/03639045.2012.752497

Dubbini, 2014, Influence of pH and method of crystallization on the solid physical form of indomethacin, Int J Pharm, 473, 536, 10.1016/j.ijpharm.2014.07.030

Kao, 2015, Thermoanalytical and spectroscopic studies on amorphization and phase transition of amorphous indomethacin prepared by two melt-cooling processes, Sci Lett, 4, 148

Surwase, 2013, Indomethacin: new polymorphs of an old drug, Mol Pharm, 10, 4472, 10.1021/mp400299a

Kaneniwa, 1985, Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol, Chem Pharm Bull (Tokyo), 33, 3447, 10.1248/cpb.33.3447

Lin, 1992, Isolation and solid-state characteristics of a new crystal form of indomethacin, J Pharm Sci, 81, 572, 10.1002/jps.2600810622

Crowley, 2002, Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability, J Pharm Sci, 91, 492, 10.1002/jps.10028

Trotta, 1999, Influence of phase transformation on indomethacin release from microemulsions, J Control Release, 60, 399, 10.1016/S0168-3659(99)00094-2

Otsuka, 1986, Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding, Chem Pharm Bull (Tokyo), 34, 1784, 10.1248/cpb.34.1784

Guo, 2011, A kinetic study of the polymorphic transformation of nimodipine and indomethacin during high shear granulation, AAPS PharmSciTech, 12, 610, 10.1208/s12249-011-9628-8

Vyazovkin, 2007, Effect of physical aging on nucleation of amorphous indomethacin, J Phys Chem B, 111, 7283, 10.1021/jp0700027

Taylor, 1997, Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions, Pharm Res, 14, 1691, 10.1023/A:1012167410376

Lin, 2014, An investigation of indomethacin-nicotinamide cocrystal formation induced by thermal stress in the solid or liquid state, J Pharm Sci, 103, 2386, 10.1002/jps.24056

Karmwar, 2011, Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods, Int J Pharm, 417, 94, 10.1016/j.ijpharm.2010.12.019

Arndt, 2000, Poly(vinyl alcohol)/poly(acrylic acid) hydrogels: FT-IR spectroscopic characterization of crosslinking reaction and work at transition point, Acta Polymer, 50, 383, 10.1002/(SICI)1521-4044(19991201)50:11/12<383::AID-APOL383>3.0.CO;2-Z

Andronis, 1997, Effects of sorbed water on the crystallization of indomethacin from the amorphous state, J Pharm Sci, 86, 346, 10.1021/js9602711